Cargando…

Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease

BACKGROUND: Some reports suggest that psychotic features may occur in the early stages of Parkinson’s disease (PD), but sensitive tools have not been utilized. OBJECTIVE: The aim was to evaluate the presence of psychotic symptoms using detailed scales and to assess the association with clinical char...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachi, Ioanna, Papadopoulos, Vassilis, Koros, Christos, Simitsi, Athina Maria, Bougea, Anastasia, Bozi, Maria, Papagiannakis, Nikos, Soldatos, Rigas Filippos, Kolovou, Dimitra, Pantes, George, Scarmeas, Nikolaos, Paraskevas, Georgios, Voumvourakis, Konstantinos, Papageorgiou, Sokratis G., Kollias, Konstantinos, Stefanis, Nikos, Stefanis, Leonidas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657660/
https://www.ncbi.nlm.nih.gov/pubmed/37840503
http://dx.doi.org/10.3233/JPD-230056
_version_ 1785148185069486080
author Pachi, Ioanna
Papadopoulos, Vassilis
Koros, Christos
Simitsi, Athina Maria
Bougea, Anastasia
Bozi, Maria
Papagiannakis, Nikos
Soldatos, Rigas Filippos
Kolovou, Dimitra
Pantes, George
Scarmeas, Nikolaos
Paraskevas, Georgios
Voumvourakis, Konstantinos
Papageorgiou, Sokratis G.
Kollias, Konstantinos
Stefanis, Nikos
Stefanis, Leonidas
author_facet Pachi, Ioanna
Papadopoulos, Vassilis
Koros, Christos
Simitsi, Athina Maria
Bougea, Anastasia
Bozi, Maria
Papagiannakis, Nikos
Soldatos, Rigas Filippos
Kolovou, Dimitra
Pantes, George
Scarmeas, Nikolaos
Paraskevas, Georgios
Voumvourakis, Konstantinos
Papageorgiou, Sokratis G.
Kollias, Konstantinos
Stefanis, Nikos
Stefanis, Leonidas
author_sort Pachi, Ioanna
collection PubMed
description BACKGROUND: Some reports suggest that psychotic features may occur in the early stages of Parkinson’s disease (PD), but sensitive tools have not been utilized. OBJECTIVE: The aim was to evaluate the presence of psychotic symptoms using detailed scales and to assess the association with clinical characteristics. METHODS: Healthy controls and patients within three years of PD onset were recruited. Participants were examined for psychotic symptoms using two different instruments: the Comprehensive Assessment of At-Risk Mental States (CAARMS) and a 10 question PD specific psychosis severity scale (10PDQ). In the PD group, medication use, motor and non-motor symptoms were documented. RESULTS: Based on CAARMS and 10PDQ scales, psychotic features were present in 39% (27/70) of patients and 4% (3/74) of controls. The prevalence of passage hallucinations and illusions was significantly higher in PD compared to the control group. The presence of PD-associated psychotic features was not significantly affected by medication, motor severity or global cognitive status. Higher prevalence of overall non-motor manifestations, REM sleep behavior disorder (RBD) and depressive symptoms was significantly associated with the manifestation of psychotic features in PD [(adjusted OR:1.3; 95% CI:1.1-1.6; p = 0.003), (adjusted OR:1.3; 95% CI:1.0-1.6; p = 0.023), and (adjusted OR:1.2; 95% CI:1.0-1.4;p = 0.026)]. CONCLUSIONS: Psychotic phenomena mainly of minor nature are highly common in early PD. Cumulative non-motor symptoms, RBD and depressive features are associated with the presence of psychotic symptoms in this non-demented, early-stage PD population. More studies are needed to clarify the mechanisms that contribute to the onset of psychotic features in early PD.
format Online
Article
Text
id pubmed-10657660
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-106576602023-11-19 Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease Pachi, Ioanna Papadopoulos, Vassilis Koros, Christos Simitsi, Athina Maria Bougea, Anastasia Bozi, Maria Papagiannakis, Nikos Soldatos, Rigas Filippos Kolovou, Dimitra Pantes, George Scarmeas, Nikolaos Paraskevas, Georgios Voumvourakis, Konstantinos Papageorgiou, Sokratis G. Kollias, Konstantinos Stefanis, Nikos Stefanis, Leonidas J Parkinsons Dis Research Report BACKGROUND: Some reports suggest that psychotic features may occur in the early stages of Parkinson’s disease (PD), but sensitive tools have not been utilized. OBJECTIVE: The aim was to evaluate the presence of psychotic symptoms using detailed scales and to assess the association with clinical characteristics. METHODS: Healthy controls and patients within three years of PD onset were recruited. Participants were examined for psychotic symptoms using two different instruments: the Comprehensive Assessment of At-Risk Mental States (CAARMS) and a 10 question PD specific psychosis severity scale (10PDQ). In the PD group, medication use, motor and non-motor symptoms were documented. RESULTS: Based on CAARMS and 10PDQ scales, psychotic features were present in 39% (27/70) of patients and 4% (3/74) of controls. The prevalence of passage hallucinations and illusions was significantly higher in PD compared to the control group. The presence of PD-associated psychotic features was not significantly affected by medication, motor severity or global cognitive status. Higher prevalence of overall non-motor manifestations, REM sleep behavior disorder (RBD) and depressive symptoms was significantly associated with the manifestation of psychotic features in PD [(adjusted OR:1.3; 95% CI:1.1-1.6; p = 0.003), (adjusted OR:1.3; 95% CI:1.0-1.6; p = 0.023), and (adjusted OR:1.2; 95% CI:1.0-1.4;p = 0.026)]. CONCLUSIONS: Psychotic phenomena mainly of minor nature are highly common in early PD. Cumulative non-motor symptoms, RBD and depressive features are associated with the presence of psychotic symptoms in this non-demented, early-stage PD population. More studies are needed to clarify the mechanisms that contribute to the onset of psychotic features in early PD. IOS Press 2023-11-03 /pmc/articles/PMC10657660/ /pubmed/37840503 http://dx.doi.org/10.3233/JPD-230056 Text en © 2023 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Report
Pachi, Ioanna
Papadopoulos, Vassilis
Koros, Christos
Simitsi, Athina Maria
Bougea, Anastasia
Bozi, Maria
Papagiannakis, Nikos
Soldatos, Rigas Filippos
Kolovou, Dimitra
Pantes, George
Scarmeas, Nikolaos
Paraskevas, Georgios
Voumvourakis, Konstantinos
Papageorgiou, Sokratis G.
Kollias, Konstantinos
Stefanis, Nikos
Stefanis, Leonidas
Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
title Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
title_full Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
title_fullStr Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
title_full_unstemmed Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
title_short Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
title_sort comprehensive evaluation of psychotic features and their clinical correlates in early parkinson’s disease
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657660/
https://www.ncbi.nlm.nih.gov/pubmed/37840503
http://dx.doi.org/10.3233/JPD-230056
work_keys_str_mv AT pachiioanna comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT papadopoulosvassilis comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT koroschristos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT simitsiathinamaria comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT bougeaanastasia comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT bozimaria comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT papagiannakisnikos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT soldatosrigasfilippos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT kolovoudimitra comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT pantesgeorge comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT scarmeasnikolaos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT paraskevasgeorgios comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT voumvourakiskonstantinos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT papageorgiousokratisg comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT kolliaskonstantinos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT stefanisnikos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease
AT stefanisleonidas comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease